Needham analyst Alex Henderson initiates coverage on HashiCorp (NASDAQ:HCP) with a Hold rating.
Evogene Subsidiary Lavie Bio Highlights Commercial Launch Of Its First Product, LAV.211, An Inoculant For Yield Improvement, Under The Brand Name ‘result’
Lavie Bio Ltd., a subsidiary of Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), and a leading ag-biologicals company focusing on improving food quality and agricultural productivity and sustainability through the introduction
